🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the benefit of 177Lu-DOTATATE versus...
Status
Withdrawn
Location
Jules Bordet Institute
Start Date
2014-12
Trial ID
NCT01860742
Treatments Being Tested
This pilot phase II trial studies how effective pembrolizumab and liver-dir...
Status
Completed
Location
University of California, San Francisco
Start Date
2018-08-27
Trial ID
NCT03457948
This is a randomized phase II non-comparative study. Patients with gastroen...
Status
Terminated
Location
Irst Irccs
Start Date
2013-12
Trial ID
NCT02489604
Treatments Being Tested
Background: A neuroendocrine tumor is a rare type of tumor. It comes from ...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2022-10-03
Trial ID
NCT04086485
Treatments Being Tested
Neuroendocrine tumours (NETs) are rare, slow growing, and diagnosis is ofte...
Status
Suspended
Location
Cross Cancer Institute
Start Date
2014-04-29
Trial ID
NCT01876771
Treatments Being Tested
Peptide receptor radionuclide therapy (PRRT) with \[177Lu\]Lu-\[DOTA0,Tyr3\...
Status
Terminated
Location
Multiple Locations
Start Date
2007-03-01
Trial ID
NCT07012330
Treatments Being Tested
This phase 1 dose-escalation study is designed to evaluate the safety and t...
Status
Recruiting
Location
Peter MacCallum Cancer Centre
Start Date
2021-12-08
Trial ID
NCT05053854
Treatments Being Tested
The aim of this phase I-II study is to evaluate the efficacy and toxicity o...
Status
Completed
Location
Giovanni Paganelli
Start Date
2015-09-02
Trial ID
NCT02736500
Treatments Being Tested
This study is a phase 2, open, single-site trial. The primary objective of ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-12-18
Trial ID
NCT06121271
Treatments Being Tested
The purpose of this study is to determine if 68Gallium-octreotate and 18Flu...
Status
Completed
Location
Jules Bordet Institute
Start Date
2013-05
Trial ID
NCT01842165
Treatments Being Tested